Xiang Zhou

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Wenzhou Medical University, Peking Union Medical College Hospital, Fudan University Shanghai Cancer Center, Augenklinik Universitätsklinikum Würzburg, Universitätsklinikum Würzburg, Hangzhou Hospital of Traditional Chinese Medicine, Zhejiang Taizhou Hospital, Hainan Medical University · ORCID：0000-0003-3885-0919

发表论文 115 篇 · 总被引 1473 次 · h-index 17

代表论文

• Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma (2024 · Blood · 被引 59)
• EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma (2024 · Journal for ImmunoTherapy of Cancer · 被引 46)
• Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today? (2024 · La Presse Médicale · 被引 9)
• Carfilzomib-specific proteasome β5/β2 inhibition drives cardiotoxicity via remodeling of protein homeostasis and the renin-angiotensin-system (2025 · iScience · 被引 8)
• Haemaphysalis longicornis subolesin controls the infection and transmission of severe fever with thrombocytopenia syndrome virus (2025 · npj Vaccines · 被引 6)
• Bispecific antibodies in multiple myeloma: maximizing potential through rational combination therapies (2025 · Blood Reviews · 被引 5)